Damien Breheny
Papers
1
Total Citations
54
H-Index
1
About
Damien Breheny is a leading toxicologist whose research focuses on the comparative biological assessment of novel tobacco and nicotine products. His work is central to understanding how next-generation products, such as tobacco heating systems, may reduce harm compared to conventional cigarettes. Breheny’s major contribution lies in pioneering in vitro screening approaches to evaluate the toxicological impact of these products. His most-cited paper, “Assessment of novel tobacco heating product THP1.0,” with 54 citations, exemplifies his role in developing contemporary, high-throughput methods to compare the biological effects of heated tobacco emissions against traditional cigarette smoke. This foundational study has helped shape regulatory science and product stewardship. Beyond this, Breheny has contributed to a broader body of work that systematically characterizes reduced-risk potential through cellular and molecular endpoints. His research is instrumental for scientists and regulators seeking evidence-based frameworks for tobacco harm reduction, making him a key figure in the transition toward less harmful nicotine delivery systems.
Research Focus
Key Achievements
Top Papers
- 1